Abstract
The renal osteodystrophies represent the metabolic consequences of (1) vitamin D resistance, (2) secondary hyperplasia of the parathyroids, and (3) the changes in serum PO4= and Ca++ secondary to the renal insufficiency per se.
The osseous lesion in any given patient with chronic renal failure may be osteitis fibrosa, rickets (osteomalacia), calcium deficiency osteoporosis or any combination of these. The concentration of Ca++ and PO4= in the serum is determined by the degree of renal failure and the skeletal response to parathyroid hormone.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- GOLDMAN R., BASSETT S. H. Phosphorus excretion in renal failure. J Clin Invest. 1954 Dec;33(12):1623–1628. doi: 10.1172/JCI103042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HARRISON H. C., HARRISON H. E., PARK E. A. Vitamin D and citrate metabolism; effect of vitamin D in rats fed diets adequate in both calcium and phosphorus. Am J Physiol. 1958 Feb;192(2):432–436. doi: 10.1152/ajplegacy.1958.192.2.432. [DOI] [PubMed] [Google Scholar]
- RASMUSSEN H. Parathyroid hormone. Nature and mechanism of action. Am J Med. 1961 Jan;30:112–128. doi: 10.1016/0002-9343(61)90068-7. [DOI] [PubMed] [Google Scholar]
- STANBURY S. W. Azotaemic renal osteodystrophy. Br Med Bull. 1957 Jan;13(1):57–60. doi: 10.1093/oxfordjournals.bmb.a069572. [DOI] [PubMed] [Google Scholar]
- STANBURY S. W., LUMB G. A., NICHOLSON W. F. Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet. 1960 Apr 9;1(7128):793–799. doi: 10.1016/s0140-6736(60)90678-4. [DOI] [PubMed] [Google Scholar]